Kyruus, a leader in provider search and scheduling solutions for health systems, recently announced that it had obtained $30 million in new funding from Francisco Partners, a global technology-focused private equity firm with extensive experience in healthcare IT. This funding comes on the heels of a $42 million Series D round the company closed last year. During this time of COVID-19, the Kyruus platform has been critical to healthcare organizations’ ability to facilitate patient access, and the additional funding will propel the company’s plans to expand its platform, broaden its footprint with health systems, and expand to new market segments.
“Kyruus exists to enable human beings to care for other human beings,” said Kyruus Co-founder and CEO Graham Gardner, MD. “We anchored our platform on the principle that healthcare organizations could better match patients to the right providers and care settings through a data-driven approach to routing and scheduling. This ability to connect patients to the appropriate care—across virtual and in-person appointments—has never been more critical. We are excited to work with the team at Francisco Partners to accelerate our impact through a range of strategic opportunities.”
Francisco Partners’ investment brings Kyruus’ total funding to more than $155 million.
“Kyruus offers an unparalleled platform for enabling healthcare organizations to route patients to the right care options and streamline the access experience,” said Francisco Partners Co-president Ezra Perlman. “At a time when major capacity constraints have converged with a rapid uptick in new care delivery methods, Kyruus is perfectly positioned to meet the industry’s evolving needs. We look forward to working with Graham and the rest of the Kyruus team to support the company’s ability to coordinate care for patients across the country.”
Kyruus pioneered the patient access category within healthcare IT. The company now serves 600 hospitals and over a quarter million healthcare providers across the U.S.
Read the original press release here.
See further coverage in: